ArticleNPJ precision oncology2025
Cell graph analysis in hepatocellular carcinoma: predicting local recurrence and identifying spatial relationship biomarkers.
Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of a multimodal AI-agent system for prognosis analysis of bladder urothelial carcinoma.NPJ precision oncology · 2026Article
- Artificial Intelligence in the Diagnosis and Prognostic Stratification of Hepatocellular Carcinoma: Current Evidence, Clinical Applications, and Future Perspectives.Biomedicines · 2026Review
- Pioneering efficient deep learning architectures for enhanced hepatocellular carcinoma prediction and clinical translation.World journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
A whole pathology section contains approximately 1,000,000 cells of various types, this large-scale heterogeneity of cells and non-cellular constituents constructs a mutually competitive community. Conventional pixel-based visual processing techniques are insufficient to accurately capture the complexities inherent with cell-entity deployment and formation strategy. Here, we conquered segmentation and classification of all cells on the whole pathology sections from 387 hepatocellular carcinoma (HCC) patients across six cohorts with 57 pathologists assisted. Further, an AI system called Hybrid Graph Neural Network-Transformer system (HGTs) was proposed. It precisely predicted local recurrence of postoperative HCC by analyzing cell interactions across multiple scales, from cell-to-cell, cell-community, to tissue-level interactions. The proposed HGTs outperformed existing SOTA methods, with the C-index improving by 23.1% to reach 0.823, by further integrating multimodal data, including clinical information and immunohistochemical markers. A set of spatial relational biomarkers influencing tumor prognosis was discovered and quantitatively validated. They include the frequency of tumor-lymphocyte and tumor-tumor interactions, the distribution and sparsity of key cellular communities, and the degree of fibrosis in adjacent peritumoral tissues. Utilizing the anti-tumor potential of this marker set, we're developing therapies to enhance the immune system's fight against cancer. All cell semantic segmentation datasets and code are publicly available: https://github.com/Yuan1z0825/HGTs .
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.